| Nov 10, 2025 | Metsera, Inc. | 8-K | — | — |
| Oct 17, 2025 | Metsera, Inc. | DEFM14A | $47.50 | 30.23% |
| Oct 6, 2025 | Metsera, Inc. | PREM14A | $47.50 | 30% |
| Sep 22, 2025 | Metsera, Inc. | 8-K | — | — |
| Apr 24, 2023 | Seagen Inc. | DEFM14A | $229.00 | — |
| Apr 14, 2023 | Seagen Inc. | PREM14A | $229.00 | — |
| Aug 30, 2022 | Biohaven Pharmaceutical Holding Co Ltd. | DEFM14A | $148.50 | 78.6% |
| Aug 29, 2022 | Global Blood Therapeutics, Inc. | DEFM14A | $68.50 | 35.29% |
| Aug 19, 2022 | Global Blood Therapeutics, Inc. | PREM14A | $68.50 | 35.71% |
| Jul 1, 2022 | Biohaven Pharmaceutical Holding Co Ltd. | PREM14A | $148.50 | 78.6% |
| Jan 3, 2022 | ARENA PHARMACEUTICALS INC | DEFM14A | $100.00 | 100% |
| Dec 23, 2021 | ARENA PHARMACEUTICALS INC | PREM14A | $100.00 | 100% |
| Sep 27, 2021 | Trillium Therapeutics Inc. | DEFM14A | $18.50 | 100% |
| Sep 13, 2021 | Trillium Therapeutics Inc. | PREM14A | $18.50 | 100% |
| Jun 28, 2019 | ARRAY BIOPHARMA INC | SC TO-T | — | — |